Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNA-C and NYVAC-C Preventive HIV Vaccination in Healthy Volunteers
NCT00490074Phase 2Completed
- Sponsor
- ANRS
- Start
- Jul 2007
- Primary completion
- Dec 2008
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of ZM96GPN, NYVAC HIV-C in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Jul 2007; status: completed.
02
Drugs
ZM96GPNNYVAC HIV-C
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00490074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490074.